Clinical Trial 36983

Berlin, NJ 08009


Study Summary:

A PHASE Ib, RANDOMIZED, BLINDED, PLACEBOCONTROLLED, MULTIPLE ASCENDING−DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUBCUTANEOUS BFKB8488A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS


Qualified Participants Must:

• Be between 18 and 75 years of age
• Have a BMI between 27 and 40
• Have Type II diabetes for at least 6 months
• Hba1c between 6.8% and 9.0%
• Type II diabetes can be controlled by diet or medication


Qualified Participants May Receive:

Up to $1,700


View Contact Phone Number


Research Site Profile

View Clinic Profile

Study is Available At:

Hassman Research Institute
175 Berlin Cross Keys Rd
Berlin, NJ 08009
View Clinic Location

If you meet the above criteria and live within 100 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.

or

Click "View Contact Phone Number" to get the clinic's phone number.

 


If you would like to be contacted by the clinical trial representative and live within 100 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'